Ball & CO Wealth Management Inc. Gilead Sciences, Inc. Transaction History
Ball & CO Wealth Management Inc.
- $93.9 Million
- Q2 2025
A detailed history of Ball & CO Wealth Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ball & CO Wealth Management Inc. holds 7,441 shares of GILD stock, worth $888,529. This represents 0.88% of its overall portfolio holdings.
Number of Shares
7,441
Previous 7,387
0.73%
Holding current value
$888,529
Previous $827,000
0.24%
% of portfolio
0.88%
Previous 0.89%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...